Full Text View
Tabular View
No Study Results Posted
Related Studies
Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis
This study has been completed.
Study NCT00524849   Information provided by Fudan University

First Received on September 4, 2007.   Last Updated on September 13, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metastatic Breast Cancer
Bone Metastases
Additional conditions recognized in this trial
Bone Marrow Diseases
Bone Neoplasms
Breast Neoplasms
Neoplasm Metastasis
Neoplasms, Second Primary
More general conditions related to this trial
Bone Diseases
Breast Diseases
Hematologic Diseases
Musculoskeletal Diseases
Neoplasms
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Skin Diseases
Interventions listed in this trial
Zoledronic acid
Additional drug interventions recognized in this trial
Diphosphonates
Endothelial Growth Factors
More general drug interventions related to this trial
Bone Density Conservation Agents
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Fudan University
Novartis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services